![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MD Hollenberg, M Saifeddine and B al-Ani
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Alberta, Canada.
We measured in rat aorta rings the relaxant activity of a number of peptides derived from the activating sequence (SLIGRL, or PP6) of the proteinase-activated receptor-2 (PAR-2). The relaxant action of PP6-NH2 mimicked the action of low concentrations of trypsin (0.5-1 unit/ml; 1- 2 nM), was dependent on an intact endothelium, and was blocked by N- omega-nitro-L-arginine methyl ester but not by N-omega-nitro-D-arginine methyl ester. The relaxant actions of PP6, SLIGRL-NH2 (PP6-NH2), SLIGR (PP5), and SLIGR-NH2 (PP5-NH2) were comparable in magnitude, with relative potencies of PP6-NH2 > or = PP6 > PP5-NH2 > PP5. Peptides lacking either a leucine at position 2 (SAIGRL) or an arginine at position 5 (SLIGAL) exhibited markedly reduced or no relaxant activity; nevertheless, the tetrapeptide LIGR-NH2 exhibited low but detectable intrinsic activity. With the use of reverse-transcriptase/polymerase chain reaction, we documented the presence of PAR-2 mRNA in aorta tissue and determined that the rat aorta amino-terminal receptor- activating sequence was the same as that reported for the murine PAR-2 receptor. We concluded that the rat aorta tissue has a PAR-2 receptor that can be activated by peptides as short as four amino acids; the leucine and arginine at positions 2 and 5, respectively, of the proteolytically revealed PAR-2 receptor-activating sequence play key roles in regulating receptor function.
This article has been cited by other articles:
|
|
 |
|
  D. A. Vesey, W. A. Kruger, P. Poronnik, G. C. Gobe, and D. W. Johnson Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1441 - F1449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Adam, K. K. Hansen, O. F. Astudillo, L. Coulon, F. Bex, X. Duhant, E. Jaumotte, M. D. Hollenberg, and A. Jacquet The House Dust Mite Allergen Der p 1, Unlike Der p 3, Stimulates the Expression of Interleukin-8 in Human Airway Epithelial Cells via a Proteinase-activated Receptor-2-independent Mechanism J. Biol. Chem., March 17, 2006; 281(11): 6910 - 6923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dulon, D. Leduc, G. S. Cottrell, J. D'Alayer, K. K. Hansen, N. W. Bunnett, M. D. Hollenberg, D. Pidard, and M. Chignard Pseudomonas aeruginosa Elastase Disables Proteinase-Activated Receptor 2 in Respiratory Epithelial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 411 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kawabata, S. Kubo, T. Ishiki, N. Kawao, F. Sekiguchi, R. Kuroda, M. D. Hollenberg, T. Kanke, and N. Saito Proteinase-Activated Receptor-2-Mediated Relaxation in Mouse Tracheal and Bronchial Smooth Muscle: Signal Transduction Mechanisms and Distinct Agonist Sensitivity J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 402 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kawabata, T. Kanke, D. Yonezawa, T. Ishiki, M. Saka, M. Kabeya, F. Sekiguchi, S. Kubo, R. Kuroda, M. Iwaki, et al. Potent and Metabolically Stable Agonists for Protease-Activated Receptor-2: Evaluation of Activity in Multiple Assay Systems in Vitro and in Vivo J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1098 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. McGuire, M. Saifeddine, C. R. Triggle, K. Sun, and M. D. Hollenberg 2-Furoyl-LIGRLO-amide: A Potent and Selective Proteinase-Activated Receptor 2 Agonist J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1124 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Al-Ani, K. K. Hansen, and M. D. Hollenberg Proteinase-Activated Receptor-2: Key Role of Amino-Terminal Dipeptide Residues of the Tethered Ligand for Receptor Activation Mol. Pharmacol., January 1, 2004; 65(1): 149 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cicala, S. Morello, V. Vellecco, B. Severino, L. Sorrentino, and G. Cirino Basal nitric oxide modulates vascular effects of a peptide activating protease-activated receptor 2 Cardiovasc Res, November 1, 2003; 60(2): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Gui, R. Loutzenhiser, and M. D. Hollenberg Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney Am J Physiol Renal Physiol, July 1, 2003; 285(1): F95 - F104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Al-Ani, S. J. Wijesuriya, and M. D. Hollenberg Proteinase-Activated Receptor 2: Differential Activation of the Receptor by Tethered Ligand and Soluble Peptide Analogs J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1046 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Hollenberg and S. J. Compton International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2002; 54(2): 203 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bhattacharya, G. F. Smith, and M. L. Cohen Effect of LY287045, a Thrombin/Trypsin Inhibitor, on Thrombin and Trypsin-Induced Aortic Contraction and Relaxation J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 573 - 581. [Abstract] [Full Text]
|
|
|
|
|
|
A. Bhattacharya and M. L. Cohen Vascular Contraction and Relaxation to Thrombin and Trypsin: Thrombomodulin Preferentially Attenuates Thrombin-Induced Contraction J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 284 - 290. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Sharlow, C. Paine, L Babiarz, M Eisinger, S Shapiro, and M Seiberg The protease-activated receptor-2 upregulates keratinocyte phagocytosis J. Cell Sci., January 9, 2000; 113(17): 3093 - 3101. [Abstract] [PDF]
|
|
|
|
 |
|
 C. G. Sobey, J. D. Moffatt, T. M. Cocks, and H. A. Kontos Evidence for Selective Effects of Chronic Hypertension on Cerebral Artery Vasodilatation to Protease-Activated Receptor-2 Activation • Editorial Comment Stroke, September 1, 1999; 30(9): 1933 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Al-Ani, M. Saifeddine, A. Kawabata, B. Renaux, S. Mokashi, and M. D. Hollenberg Proteinase-Activated Receptor 2 (PAR2): Development of a Ligand-Binding Assay Correlating with Activation of PAR2 by PAR1- and PAR2-Derived Peptide Ligands J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 753 - 760. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Cicala, A. Pinto, M. Bucci, R. Sorrentino, B. Walker, P. Harriot, A. Cruchley, S. Kapas, G. L. Howells, and G. Cirino Protease-Activated Receptor-2 Involvement in Hypotension in Normal and Endotoxemic Rats In Vivo Circulation, May 18, 1999; 99(19): 2590 - 2597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kawabata, M. Saifeddine, B. Al-Ani, L. Leblond, and M. D. Hollenberg Evaluation of Proteinase-Activated Receptor-1 (PAR1) Agonists and Antagonists Using a Cultured Cell Receptor Desensitization Assay: Activation of PAR2 by PAR1-Targeted Ligands J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 358 - 370. [Abstract] [Full Text]
|
|
|
|
|
|
C. G. Sobey, T. M. Cocks, and Z. S. Katusic Activation of Protease-Activated Receptor-2 (PAR-2) Elicits Nitric Oxide–Dependent Dilatation of the Basilar Artery In Vivo • Editorial Comment Stroke, July 1, 1998; 29(7): 1439 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Hamilton, P. B. Nguyen, and T. M. Cocks Atypical Protease-Activated Receptor Mediates Endothelium-Dependent Relaxation of Human Coronary Arteries Circ. Res., June 29, 1998; 82(12): 1306 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Dery, C. U. Corvera, M. Steinhoff, and N. W. Bunnett Proteinase-activated receptors: novel mechanisms of signaling by serine proteases Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1429 - C1452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Molino, P. N. Raghunath, A. Kuo, M. Ahuja, J. A. Hoxie, L. F. Brass, and E. S. Barnathan Differential Expression of Functional Protease-Activated Receptor-2 (PAR-2) in Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 825 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Molino, M. J. Woolkalis, J. Reavey-Cantwell, D. Pratico, P. Andrade-Gordon, E. S. Barnathan, and L. F. Brass Endothelial Cell Thrombin Receptors and PAR-2. TWO PROTEASE-ACTIVATED RECEPTORS LOCATED IN A SINGLE CELLULAR ENVIRONMENT J. Biol. Chem., April 25, 1997; 272(17): 11133 - 11141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Howells, M. Macey, C Chinni, L Hou, M. Fox, P Harriott, and S. Stone Proteinase-activated receptor-2: expression by human neutrophils J. Cell Sci., January 4, 1997; 110(7): 881 - 887. [Abstract] [PDF]
|
|
|
|
|
|
BrianD. Blackhart, K. Emilsson, D. Nguyen, W. Teng, ArnoldJ. Martelli, S. Nystedt, J. Sundelin, and RobertM. Scarborough Ligand Cross-reactivity within the Protease-activated Receptor Family J. Biol. Chem., July 12, 1996; 271(28): 16466 - 16471. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
